MoneyWeek Talks

Merryn talks to Raoul Pal, CEO of Global Macro Investor and Real Vision Group about the terrifying levels of risk in the markets right now, and why that’s driven him to sell all his gold and put the proceeds into cryptocurrencies.

Merryn talks to Jupiter’s Ned Naylor-Leyland about gold as a way of genuinely diversifying your portfolio; why bitcoin could eventually return to being just “dark money on the internet”; and the many attractions and even more dangers of silver. And if you want to watch Merryn's webcast with Baillie Gifford's Charles Plowden, click here http://ow.ly/rLoO50Djqff

Merryn and John talk about the many obvious signs of a bubble in certain assets, including tech stocks, TikTok, and stock-trading 12-year olds. It's clear things are not normal – but is it different this time?

Merryn talks to bitcoin experts Dominic Frisby and Charlie Morris to get the lowdown on the cryptocurrency to find out why it's such a huge global phenomenon and why you really should get hold of some.

Merryn and John talk about the US market's epic bubble, Tesla's nutty valuation and how bitcoin mania has taken over the world – is it really gold for the 21st century and are projections of it hitting a million dollars that outlandish? Plus, if every country in the world cancelled everyone's debt all at once, would that really be so bad?

Merryn talks to MoneyWeek's favourite macro-analyst Russell Napier on how the phenomenal levels of public and private debt will inevitably lead to inflation and financial repression, what that is, and how it will affect you your money, and the global economy.

Merryn talks to John talk about how the last nine months have affected the economy and the markets, and to to two entrepreneurs – Tommy Crooks of the Edinburgh Natural Skincare Company and Felicia Hjertman of startup fund investment platform Tillit – about how they have coped. Plus, bitcoin, inflation, and what to buy in 2021.

Merryn talks to independent economist Julian Jessop about how the vaccine should restart the stalled economic recovery as both consumers and businesses return to normal life.

The news of Covid vaccines has delighted many. But not Argonaut Capital's Barry Norris. He tells Merryn why vaccines aren't the panacea people think they are, and how our extended lockdown could have permanently changed our way of life. Plus, he picks one health-focused value stock to buy now.

Merryn talks to Stephen Yiu of the Blue Whale Growth Fund about his investment approach and the sectors he likes, plus why you should stick with top quality stocks (and why there are more of them in the US than the UK).

Merryn talks to Japan expert Jonathan Allum who explains why many people's ideas of Japan are misguided, and why if you're looking to profit from a post-global Covid recovery, it's an interesting place for investors to start.

Merryn talks to Peter Tasker of Arcus, a specialist Japanese equity investment firm, about the extraordinary resilience of Japanese companies, how the country has handled the pandemic, the many attractions for investors, and why you should join Warren Buffett in buying in.

There are huge opportunities right now in UK stocks, says Fidelity's Alex Wright. Here, he talks to Merryn about value vs growth, the prospect of a vaccine-driven, V-shaped recovery, what will bring foreign investors back to UK markets, and what he's buying now.

Jim Patterson, managing editor of the Kiplinger Letter, our sister publication in the US, joins John to talk about the US election – its effect on the markets, the economy and investors. And if Joe Biden has indeed won, how will that affect America's relations with other world powers, and what can he actually get done in the next four years with the Senate still in Republican hands? Plus, a look a...

Alain Caffort of the Pictet Family Fund explains the attractions of family-owned businesses, runs through some of his favourite companies, and picks one to hold for the next 20 years.

Merryn talks to Dennis Jackson and James Henderson of the Law Debenture Corporation about what makes the trust unique, the regulatory tailwinds it can profit from, and what they're buying now.

Merryn talks to Shaniel Ramjee of Pictet Asset Management about where to find the best returns in global markets right now – the continued growth of technology; why China will outperform as its economy steams ahead (plus the risks involved for investors); and why the UK will continue to lag for a while yet.

Merryn and John discuss the extraordinary idea of negative interest rates and explain why as far as they can see they just don't work. Plus, a genius business idea involving guarding piles of cash, and the second in our 20th anniversary questions.

Merryn and John discuss the effects of lockdowns on the economy, particularly on the private sector where already financially fragile workers are laid off, compared to the public sector with their final salary pension schemes. Plus, why you should rebalance your portfolio into China, and a question for readers to go in the 20th anniversary issue of MoneyWeek magazine.

Merryn talks to Dr Paul Jordan, Anna Macdonald, and Dr Gareth Blades of Amati Global investors about some of their favourite small UK companies - including the opportunities in healthcare and biotech stocks, and how the sector has responded to the pandemic.

Merryn talks to Fidelity's Dale Nicholls about investing in Chinese companies - the sectors he likes, the themes he's following, and why Chinese equities will only grow in importance as the market matures over the coming years.

Merryn and John talk to MoneyWeek regular James Ferguson about the rise in infections in coronavirus and what the data is really telling us.

Merryn talks to Mark Slater of the Slater Growth fund about why investors have abandoned the UK – and why they are wrong to have done so. Plus, he picks two of his favourite British stocks.

A brief summary of this episode

There are very few ways to get out of the debt hole we have dug, economist and author George Magnus tells Merryn, and inflation is one of the most likely. Not tomorrow, perhaps – not even by the end of the year. But it is coming.